← Back to headlines
Lexicon Pharmaceuticals to Present Phase 2b Pilavapadin Data
Lexicon Pharmaceuticals (LXRX) is scheduled to present data from its Phase 2b trial of Pilavapadin.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
UK Twin Sisters Discover They Are Half-Sisters After 50 Years
13m ago
Seoul Hosts 'Power Nap Contest' Amid South Korea's Sleep Deprivation
16m ago
North Macedonia Introduces Telemedicine with Diaspora Doctors
19m ago
Tragedy on the Horehron swing: three people hospitalized after the fall of a four-meter attraction
24m ago